89 related articles for article (PubMed ID: 24066968)
1. The liver-targeting study of the N-galactosylated chitosan in vivo and in vitro.
Liang M; Zheng X; Tu L; Ma Z; Wang Z; Yan D; Shen Z
Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):423-8. PubMed ID: 24066968
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
Kim EM; Jeong HJ; Park IK; Cho CS; Kim CG; Bom HS
J Nucl Med; 2005 Jan; 46(1):141-5. PubMed ID: 15632044
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting.
Jiang HL; Kwon JT; Kim YK; Kim EM; Arote R; Jeong HJ; Nah JW; Choi YJ; Akaike T; Cho MH; Cho CS
Gene Ther; 2007 Oct; 14(19):1389-98. PubMed ID: 17637795
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18 labeled galactosylated chitosan for asialoglycoprotein-receptor-mediated hepatocyte imaging.
Yang W; Mou T; Guo W; Jing H; Peng C; Zhang X; Ma Y; Liu B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4840-4. PubMed ID: 20634070
[TBL] [Abstract][Full Text] [Related]
5.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
6. Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
Kim EM; Jeong HJ; Kim SL; Sohn MH; Nah JW; Bom HS; Park IK; Cho CS
Nucl Med Biol; 2006 May; 33(4):529-34. PubMed ID: 16720245
[TBL] [Abstract][Full Text] [Related]
7. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.
Dong L; Gao S; Diao H; Chen J; Zhang J
J Biomed Mater Res A; 2008 Mar; 84(3):777-84. PubMed ID: 17635017
[TBL] [Abstract][Full Text] [Related]
8. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
9. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier.
Park IK; Park YH; Shin BA; Choi ES; Kim YR; Akaike T; Cho CS
J Control Release; 2000 Oct; 69(1):97-108. PubMed ID: 11018549
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes.
Kim TH; Kim SI; Akaike T; Cho CS
J Control Release; 2005 Jul; 105(3):354-66. PubMed ID: 15949861
[TBL] [Abstract][Full Text] [Related]
12. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection.
Park IK; Jiang HL; Cook SE; Cho MH; Kim SI; Jeong HJ; Akaike T; Cho CS
Arch Pharm Res; 2004 Dec; 27(12):1284-9. PubMed ID: 15648108
[TBL] [Abstract][Full Text] [Related]
14. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.
Cheng X; Zhang F; Zhou G; Gao S; Dong L; Jiang W; Ding Z; Chen J; Zhang J
Drug Deliv; 2009 Apr; 16(3):135-44. PubMed ID: 19514973
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
Mi FL; Wu YY; Chiu YL; Chen MC; Sung HW; Yu SH; Shyu SS; Huang MF
Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
[TBL] [Abstract][Full Text] [Related]
16. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
Bu L; Gan LC; Guo XQ; Chen FZ; Song Q; Qi-Zhao ; Gou XJ; Hou SX; Yao Q
Int J Pharm; 2013 Aug; 452(1-2):355-62. PubMed ID: 23685116
[TBL] [Abstract][Full Text] [Related]
17. Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold.
Seo SJ; Kim IY; Choi YJ; Akaike T; Cho CS
Biomaterials; 2006 Mar; 27(8):1487-95. PubMed ID: 16188312
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of lactobionic-loaded chitosan microcapsules as potential drug carriers targeting the liver.
Zhang J; Li C; Xue ZY; Cheng HW; Huang FW; Zhuo RX; Zhang XZ
Acta Biomater; 2011 Apr; 7(4):1665-73. PubMed ID: 21130904
[TBL] [Abstract][Full Text] [Related]
19. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
Iacobazzi RM; Porcelli L; Lopedota AA; Laquintana V; Lopalco A; Cutrignelli A; Altamura E; Di Fonte R; Azzariti A; Franco M; Denora N
Int J Pharm; 2017 Aug; 528(1-2):485-497. PubMed ID: 28624661
[TBL] [Abstract][Full Text] [Related]
20. Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex.
Fumoto S; Kawakami S; Shigeta K; Higuchi Y; Yamashita F; Hashida M
J Pharmacol Exp Ther; 2005 Nov; 315(2):484-93. PubMed ID: 16033911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
